News

Published on 15 Jan 2024 on Simply Wall St. via Yahoo Finance

Gritstone bio (NASDAQ:GRTS) investors are sitting on a loss of 87% if they invested three years ago


Article preview image

Gritstone bio, Inc. (NASDAQ:GRTS) shareholders will doubtless be very grateful to see the share price up 52% in the last month. But the last three years have seen a terrible decline. To wit, the share price sky-dived 87% in that time. So we're relieved for long term holders to see a bit of uplift. But the more important question is whether the underlying business can justify a higher price still. While a drop like that is definitely a body blow, money isn't as important as health and happiness.

With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.

See our latest analysis for Gritstone bio

NASDAQ.GRTS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Gritstone (GRTS) Plummets 58% in a Week: Here's Why

Gritstone Bio GRTS is a clinical-stage biotechnology company focused on developing vaccines targe...

Zacks via Yahoo Finance 4 Apr 2024

Nasdaq Down Over 1%; VivoPower International Shares Spike Higher - Acorda Therapeutics...

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on ...

Benzinga 2 Apr 2024

What's Going On With Small Cap Cancer Vaccine Focused Gritstone Bio Stock On Tuesday?

Tuesday, Gritstone Bio Inc (NASDAQ:GRTS) released preliminary data from the ongoing, signal-seeki...

Benzinga via Yahoo Finance 2 Apr 2024

Gritstone Bio launches public stock and warrant offering

Gritstone Bio, Inc. (NASDAQ:GRTS), a clinical-stage biotechnology company, has announced the...

Investing.com 1 Apr 2024

Do Options Traders Know Something About Gritstone bio (GRTS) Stock We Don't?

Investors in Gritstone bio, Inc. GRTS need to pay close attention to the stock based on moves in ...

Zacks via Yahoo Finance 18 Mar 2024

Gritstone bio Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates

Gritstone bio Inc. (GRTS) came out with a quarterly loss of $0.26 per share versus the Zacks Cons...

Zacks via Yahoo Finance 5 Mar 2024

Gritstone bio (NASDAQ:GRTS) investors are sitting on a loss of 87% if they invested three years ago

Gritstone bio, Inc. (NASDAQ:GRTS) shareholders will doubtless be very grateful to see the share p...

Simply Wall St. via Yahoo Finance 15 Jan 2024

Gritstone bio Inc. (GRTS) Upgraded to Buy: What Does It Mean for the Stock?

Gritstone bio Inc. (GRTS) could be a solid addition to your portfolio given its recent upgrade to...

Zacks via Yahoo Finance 16 Oct 2023

retail investors who own 43% along with institutions invested in Gritstone bio, Inc. (NASDAQ:GRTS)...

Key Insights Gritstone bio's significant retail investors ownership suggests that the key decisio...

Simply Wall St. via Yahoo Finance 5 Oct 2023

What Does The Future Hold For Gritstone bio, Inc. (NASDAQ:GRTS)? These Analysts Have Been Cutting...

The latest analyst coverage could presage a bad day for Gritstone bio, Inc. (NASDAQ:GRTS), with t...

Simply Wall St. via Yahoo Finance 14 Aug 2023